Home/Filings/4/0001179110-20-002269
4//SEC Filing

YOOR BRIAN B 4

Accession 0001179110-20-002269

CIK 0000001800other

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 5:19 PM ET

Size

8.1 KB

Accession

0001179110-20-002269

Insider Transaction Report

Form 4
Period: 2020-02-21
YOOR BRIAN B
Senior Vice President and CFO
Transactions
  • Award

    Common shares without par value

    2020-02-21+14,036128,417 total
  • Award

    Option (right to buy)

    2020-02-21+85,56285,562 total
    Exercise: $87.72From: 2021-02-21Exp: 2030-02-20Common shares (85,562 underlying)
Holdings
  • Common shares without par value

    (indirect: By Trust)
    2,248
Footnotes (3)
  • [F1]These shares represent performance-based restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
  • [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 21, 2020.
  • [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 28,520 on February 21, 2021, 28,521 on February 21, 2022, and 28,521 on February 21, 2023.

Issuer

ABBOTT LABORATORIES

CIK 0000001800

Entity typeother

Related Parties

1
  • filerCIK 0001643528

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:19 PM ET
Size
8.1 KB